- **Q: Why did 180 Life Sciences rebrand to ETHZilla?
**
Yanuki
ARTICLE DETAIL
Crypto Stock Jumps After Peter Thiel Buys Stake | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026 | Crypto Stock Jumps After Peter Thiel Buys Stake | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026
Finance / Crypto
Crypto Stock Jumps After Peter Thiel Buys Stake
Shares of 180 Life Sciences Corp. (ATNF), now rebranded as ETHZilla, experienced a significant surge following the announcement that Peter Thiel, the PayPal co-founder and billionaire tech investor, had acquired a 7.5% ownership stake. This...
Key Insights
- **Peter Thiel’s Investment:** Thiel acquired a 7.5% stake in 180 Life Sciences Corp (ATNF) through Founders Fund Growth Management.
- **Stock Surge:** Following the announcement, ATNF shares jumped, reflecting positive investor sentiment.
- **ETHZilla Rebrand:** The company pivoted from biotech to a digital asset treasury (DAT) business model, accumulating a significant amount of Ethereum.
- **Yield Generation Program:** ETHZilla plans to generate yield on its ETH holdings through a partnership with Electric Capital.
- **Analyst Perspective:** The shift allows faster access to capital markets and outsized shareholder returns.
In-Depth Analysis
180 Life Sciences Corp (ATNF) has transitioned from a biotech firm to a digital asset treasury, rebranding itself as ETHZilla. This strategic shift involved accumulating 82,186 ETH at an average price of $3,806.71, totaling approximately $349 million, alongside $238 million in cash equivalents.
The company’s new focus is generating yield on its Ethereum holdings through a partnership with Electric Capital, contrasting with more leveraged approaches seen in the crypto space. This move has garnered attention, particularly after Peter Thiel’s investment through Founders Fund Growth Management.
BitMine, another company with Thiel involvement, has also expanded its equity program to finance further Ethereum acquisitions, signaling continued confidence in the crypto asset. ATNF's stock movement saw an increase, reflecting market enthusiasm for the company’s new direction.
FAQ
- **Q: How much Ethereum does ETHZilla hold?
**
- **Q: What is ETHZilla’s strategy for generating yield?
**
Takeaways
- High-profile investments can significantly impact stock prices.
- Companies are increasingly exploring crypto assets for treasury management.
- Strategic shifts can provide access to capital markets and potential returns.
- Investors should monitor companies entering the crypto space for both opportunities and risks.
Discussion
Do you think this trend of companies pivoting to crypto assets will continue? Let us know!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.